Equity Investees (Tables)

9 Months Ended

Sep. 30, 2014

Equity Method Investments and Joint Ventures [Abstract]

Consolidated Financial Statements Related To Equity Investees

The following table presents information included in our Unaudited Condensed Consolidated Financial Statements related to our equity investees.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2014			2013			2014			2013
Genesis’ share of operating earnings	$	17,600		$	9,641		$	35,506		$	24,512
Amortization of excess purchase price	(2,583		)	(2,582		)	(7,749		)	(7,894		)
Net equity in earnings	$	15,017		$	7,059		$	27,757		$	16,618
Distributions received	$	21,758		$	11,610		$	49,383		$	32,624

Schedule Of Balance Sheet Information For Equity Investees

The following tables present the combined unaudited balance sheet and income statement information (on a 100% basis) of our equity investees:

	September 30, 2014		December 31, 2013
BALANCE SHEET DATA:
Assets
Current assets	$	45,840	$	70,921
Fixed assets, net	1,023,865		1,028,808
Other assets	5,507		6,823
Total assets	$	1,075,212	$	1,106,552
Liabilities and equity
Current liabilities	$	20,624	$	55,918
Other liabilities	203,104		190,578
Equity	851,484		860,056
Total liabilities and equity	$	1,075,212	$	1,106,552

Schedule Of Operations For Equity Investees

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
INCOME STATEMENT DATA:
Revenues	$	74,801	$	49,239	$	171,065	$	135,507
Operating income	$	46,096	$	28,419	$	99,199	$	75,946
Net income	$	44,881	$	27,725	$	96,402	$	73,928